Stock 6826 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Haohai Biological Technology Co., Ltd.

Equities

6826

CNE100001W69

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 am EDT 		5-day change 1st Jan Change
41.55 HKD +1.47% Intraday chart for Shanghai Haohai Biological Technology Co., Ltd. +9.34% +3.10%
Mar. 11 Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5% MT
Mar. 08 Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,079 13,946 18,971 14,509 15,993 14,394 - -
Enterprise Value (EV) 1 10,882 10,962 16,123 14,509 15,993 14,394 14,394 14,394
P/E ratio 18.5 x 30.3 x 21 x 31.3 x 15 x - 10.8 x -
Yield 1.66% 1.27% 1.67% 1.23% 2.73% - 2.83% -
Capitalization / Revenue 8.78 x 10.5 x 10.7 x 6.9 x 6.07 x 4.65 x 3.92 x 3.35 x
EV / Revenue 8.78 x 10.5 x 10.7 x 6.9 x 6.07 x 4.65 x 3.92 x 3.35 x
EV / EBITDA 26.4 x 37 x 36.2 x 37.8 x 21.9 x 19 x 15.6 x 12.9 x
EV / FCF - - 269,465,034 x - - - - -
FCF Yield - - 0% - - - - -
Price to Book 1.37 x 1.07 x 1.31 x - - - - -
Nbr of stocks (in thousands) 177,845 176,622 176,404 171,271 167,091 167,360 - -
Reference price 2 42.09 39.39 41.96 32.55 36.63 37.91 37.91 37.91
Announcement Date 2/27/20 2/25/21 2/27/22 2/27/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,604 1,332 1,767 2,103 2,635 3,094 3,522 4,297
EBITDA 1 533.6 376.6 523.8 384.1 728.7 757.5 792.5 1,118
EBIT 1 435.4 259 383.4 179.9 530.8 609.4 578.8 924.7
Operating Margin 27.14% 19.44% 21.7% 8.55% 20.15% 19.7% 16.43% 21.52%
Earnings before Tax (EBT) 1 434.3 257 382.7 235.7 508.3 610 702 925.2
Net income 1 370.8 230.1 352.2 180.5 416.1 500.6 598.5 747
Net margin 23.11% 17.27% 19.93% 8.58% 15.79% 16.18% 16.99% 17.38%
EPS 2.270 1.300 2.000 1.040 2.440 - 3.499 -
Free Cash Flow - - 70.4 - - - - -
FCF margin - - 3.98% - - - - -
FCF Conversion (EBITDA) - - 13.44% - - - - -
FCF Conversion (Net income) - - 19.99% - - - - -
Dividend per Share 0.7000 0.5000 0.7000 0.4000 1.000 - 1.071 -
Announcement Date 2/27/20 2/25/21 2/27/22 2/27/23 2/23/24 - - -
1CNY in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 S1
Net sales 1 - 701.6 1,313
EBITDA - - -
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income 1 81.18 124.1 205.2
Net margin - 17.68% 15.63%
EPS 0.4700 - -
Dividend per Share - - -
Announcement Date 4/28/23 8/17/23 8/17/23
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 3,197 2,985 2,848 - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - 70.4 - - - - -
ROE (net income / shareholders' equity) 8.18% 4.2% 6.34% 3.22% 7.45% 7.98% 9.37% 10.1%
ROA (Net income/ Total Assets) - 3.7% 5.31% - - 7.43% 8.66% 9.7%
Assets 1 - 6,225 6,638 - - 6,741 6,914 7,699
Book Value Per Share 30.70 36.90 32.00 - - - - -
Cash Flow per Share 2.140 1.480 1.940 1.330 - - - -
Capex 1 249 195 272 - 265 298 302 332
Capex / Sales 15.53% 14.66% 15.39% - 10.07% 9.63% 8.21% 7.73%
Announcement Date 2/27/20 2/25/21 2/27/22 2/27/23 2/23/24 - - -
1CNY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shanghai Haohai Biological Technology Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
37.91 CNY
Average target price
65.08 CNY
Spread / Average Target
+71.68%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. Stock Shanghai Haohai Biological Technology Co., Ltd.
+3.10% 1.98B
ABBOTT LABORATORIES Stock Abbott Laboratories
-1.86% 187B
MEDTRONIC PLC Stock Medtronic plc
-1.92% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.94% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.96% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+16.76% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.45% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.31% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6826 Stock
  4. Financials Shanghai Haohai Biological Technology Co., Ltd.